Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G17DT Effect on Gastrin Levels in Colorectal Cancer
NCT02518373Phase 2Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Apr 2000
- Primary completion
- Feb 2001
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of G17DT immunogen in colorectal cancer (CRC), sponsored by Cancer Advances, Inc.. Started Apr 2000; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02518373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518373.